Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
604
Recruiting Now
604
Top Conditions in Phase 1
NCT06982131 Phase 1
Recruiting
A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How...
Condition
Overweight
Enrollment
40 pts
Location
Netherlands
Sponsor
Hoffmann-La Roche
NCT05773937 Phase 1
Recruiting
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Condition
Advanced Malignant Solid Tumors
Enrollment
40 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience
NCT05183490 Phase 1
Recruiting
R-MVST Cells for Treatment of Viral Infections
Condition
Epstein-Barr Virus Infections
Enrollment
36 pts
Location
United States
Sponsor
Columbia University
NCT06532942 Phase 1
Recruiting
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Hea...
Condition
Healthy Volunteers
Enrollment
40 pts
Location
United States
Sponsor
Mannkind Corporation
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, ...
Condition
SLE
Enrollment
24 pts
Location
United States, Australia, Bulgaria
Sponsor
Cullinan Therapeutics Inc.
NCT07230496 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LA...
Condition
Overweight and Obesity
Enrollment
104 pts
Location
Australia
Sponsor
Laekna Limited
NCT07448194 Phase 1
Recruiting
A Phase Ia Clinical Trial of HW241045
Condition
Healthy Volunteers
Enrollment
56 pts
Location
China
Sponsor
Hubei Bio-Pharmaceutical Indus
NCT07222020 Phase 1
Recruiting
Phase 1 Study of Intravaginal KB15A
Condition
Healthy Subjects
Enrollment
24 pts
Location
United States
Sponsor
ZabBio Inc.
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Highe...
Condition
Leukemia
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
NCT03601286 Phase 1
Recruiting
Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency
Condition
Severe Combined Immunodeficiency, X-Linked
Enrollment
5 pts
Location
United Kingdom
Sponsor
Great Ormond Street Hospital f
NCT07132541 Phase 1
Recruiting
Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection o...
Condition
Pancreaticoduodenectomy
Enrollment
30 pts
Location
Egypt
Sponsor
Minia University
NCT06233942 Phase 1
Recruiting
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other...
Condition
Advanced Solid Tumor
Enrollment
308 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06006273 Phase 1
Recruiting
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in ...
Condition
Refractory Solid Tumors
Enrollment
48 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
NCT06805994 Phase 1
Recruiting
Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Int...
Condition
Staphylococcal Aureus Infection
Enrollment
175 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06876129 Phase 1
Recruiting
Pharmacologic Augmentation of TMS for Depression With D-serine
Condition
Depression
Enrollment
60 pts
Location
United States
Sponsor
Mclean Hospital
NCT07455825 Phase 1
Recruiting
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety...
Condition
Healthy Participants
Enrollment
64 pts
Location
United States
Sponsor
AstraZeneca
NCT04468841 Phase 1
Recruiting
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Condition
Follicular Lymphoma
Enrollment
100 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07433556 Phase 1
Recruiting
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Health...
Condition
Healhty
Enrollment
86 pts
Location
South Korea
Sponsor
Il-Yang Pharm. Co., Ltd.
NCT05473624 Phase 1
Recruiting
Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors
Condition
Advanced Solid Tumors
Enrollment
153 pts
Location
China
Sponsor
Jiangsu HengRui Medicine Co.,
NCT07283796 Phase 1
Recruiting
A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With R...
Condition
NHL
Enrollment
110 pts
Location
China
Sponsor
Haisco Pharmaceutical Group Co
NCT06896188 Phase 1
Recruiting
9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With ...
Condition
Pancreatic Adenocarcinoma
Enrollment
12 pts
Location
United States
Sponsor
Anwaar Saeed
NCT06083883 Phase 1
Recruiting
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Aga...
Condition
Synovial Sarcoma
Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT04781322 Phase 1
Recruiting
Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heav...
Condition
Alcohol Associated Liver Disease
Enrollment
100 pts
Location
United States
Sponsor
National Institute on Alcohol
NCT06997029 Phase 1
Recruiting
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced ...
Condition
Advanced Solid Tumor
Enrollment
234 pts
Location
United States, Denmark, Japan
Sponsor
Bristol-Myers Squibb